Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
Georg Semmler(University of Southern Denmark), Christian Datz(Paracelsus Medical University), Bernhard Wernly(Paracelsus Medical University), Laurenz Hauptmann(Medical University of Vienna), Sarah Wernly(Paracelsus Medical University), Andreas Völkerer(Paracelsus Medical University), Lorenz Semmler(Paracelsus Medical University), Elmar Aigner, Lorenz Balcar(Medical University of Vienna), David Niederseer(University of Zurich)
Cited by 70
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Virtual and augmented reality in critical care medicine: the patient’s, clinician’s, and researcher’s perspective
|Critical Care|2022|229
The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study
|Critical Care|2021|188
Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue
|International Journal of Obesity|2012|168
Prognostic relevance of serum lactate kinetics in critically ill patients
|Intensive Care Medicine|2018|166